Tag: Januvia
FDA: Common Diabetes Drug Januvia May Contain Traces of Carcinogen
Nitroso-STG-19 has been found in some samples of the drug
Sitagliptin Stimulates Distal Tubular Natriuresis in T2DM
Increase in intact plasma SDF-1α1-67 and decrease in truncated plasma SDF-1α3-67
Sitagliptin Has Neutral CV Risk Effect in Elderly With T2DM, CVD
Neutral effects on cardiovascular risk among older patients with well-controlled T2DM and CVD
Sitagliptin Not Linked to Higher Fracture Risk in Diabetes
Findings from TECOS trial show increased and decreased fracture risk with insulin, metformin
Metformin, Sitagliptin Prolong Normoglycemia Remission in DKA
Findings in African-American patients with new-onset diabetic ketoacidosis and severe hyperglycemia
Vildagliptin, Sitagliptin Have Similar Effects on Incretin
Inter-individual variability seen in L-cell feedback induced by DPP-4 inhibitors
Saxagliptin, Sitagliptin Don’t Up Hospitalized Heart Failure
No increased risk for new users of saxagliptin, sitagliptin versus other antihyperglycemic agents
ADA: Sitagliptin Shows No Major Adverse CV Effects in T2DM, CVD
Findings among patients with type 2 diabetes and established cardiovascular disease
